REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/25/2026
Back to search
Official data from USPTO
IRE ELIT RADIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
05/26/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
03/10/2020
Registration date
05/25/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/25/2021
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Fleurus, BE
Examiner
LEE, JANET H
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "IRE ELIT RADIOPHARMA" in stylized script with the "I" in "IRE" being blue and the "RE" in "IRE" being green and "ELIT" being in blue above "RADIOPHARMA". "RADIO" in "RADIOPHARMA" is in blue and "PHARMA" is in green. Both "ELIT" and "RADIOPHARMA" are situated inside a green semi-circle which opens and closes at both ends of the "E" in "IRE".
Holders and representatives
Holders
I. E. (pessoa física)
Representatives
Thomas J. Mango CANTOR COLBURN LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Radiochemical products for scientific purposes; radioactive elements for scientific purposes; radioactive elements for industrial purposes
Class 5
Radiopharmaceutical productsdiagnostic or therapy radiopharmaceutical preparations; radioactive substances and active pharmaceutical ingredients in the nature of isotopes for medical use
Class 42
Scientific technological servicesradiological analysis and monitoring in the field of radioactivity to support medical applications; scientific research and developmentradiological monitoring and measurement to support medical applications; scientific and technological consultancy and surveys in the field of radioactivity to support medical applications
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/25/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBO
PUBLISHED FOR OPPOSITION
03/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2021
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
01/21/2021
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
01/21/2021
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
01/21/2021
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
01/21/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/26/2020
GNFR
FINAL REFUSAL E-MAILED
10/26/2020
CNFR
FINAL REFUSAL WRITTEN
10/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/12/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/06/2020
GNSL
LETTER OF SUSPENSION E-MAILED
08/06/2020
CNSL
SUSPENSION LETTER WRITTEN
08/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2020
ALIE
ASSIGNED TO LIE
07/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/30/2020
GNRT
NON-FINAL ACTION E-MAILED
05/30/2020
CNRT
NON-FINAL ACTION WRITTEN
05/30/2020
DOCK
ASSIGNED TO EXAMINER
05/30/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2020
NWAP
NEW APPLICATION ENTERED
03/13/2020
Continuous trademark protection
Get notified about every new filing that threatens IRE ELIT RADIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.